TRCT
LFMD icon

Tower Research Capital (TRC)’s LifeMD LFMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Buy
5,096
+2,099
+70% +$9.26K ﹤0.01% 3507
2026
Q1 		$10.8K Buy
2,997
+152
+5% +$526 ﹤0.01% 3871
2025
Q4 		$9.7K Buy
2,845
+2,087
+275% +$10.1K ﹤0.01% 3882
2025
Q3 		$5.15K Sell
758
-3,916
-84% -$32.3K ﹤0.01% 4262
2025
Q2 		$63.7K Buy
4,674
+2,452
+110% +$23.2K ﹤0.01% 2762
2025
Q1 		$12.1K Sell
2,222
-468
-17% -$2.65K ﹤0.01% 3469
2024
Q4 		$13.3K Sell
2,690
-3,482
-56% -$18.3K ﹤0.01% 3539
2024
Q3 		$32.3K Sell
6,172
-6,544
-51% -$37.7K ﹤0.01% 2962
2024
Q2 		$87.2K Buy
12,716
+1,965
+18% +$18K ﹤0.01% 2674
2024
Q1 		$111K Buy
10,751
+6,146
+133% +$45.4K ﹤0.01% 1775
2023
Q4 		$38.2K Buy
4,605
+3,348
+266% +$24.1K ﹤0.01% 3301
2023
Q3 		$7.86K Sell
1,257
-1,366
-52% -$5.92K ﹤0.01% 4426
2023
Q2 		$11.4K Sell
2,623
-4,295
-62% -$9.54K ﹤0.01% 3981
2023
Q1 		$12K Buy
6,918
+5,733
+484% +$10.1K ﹤0.01% 4093
2022
Q4 		$2K Buy
1,185
+959
+424% +$2.15K ﹤0.01% 5385
2022
Q3 		$0 Sell
226
-2,339
-91% -$5.58K ﹤0.01% 6308
2022
Q2 		$5K Buy
2,565
+1,715
+202% +$4.26K ﹤0.01% 5068
2022
Q1 		$3K Sell
850
-2,133
-72% -$7.57K ﹤0.01% 5382
2021
Q4 		$12K Buy
2,983
+327
+12% +$1.55K ﹤0.01% 4293
2021
Q3 		$16K Buy
2,656
+215
+9% +$1.83K ﹤0.01% 3928
2021
Q2 		$29K Sell
2,441
-5,108
-68% -$58.8K ﹤0.01% 3526
2021
Q1 		$119K Buy
+7,549
New +$136K ﹤0.01% 2457

Other funds holding LFMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Tower Research Capital (TRC)'s LFMD Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its LifeMD (LFMD) stake by 70% in Q2 2026, buying an estimated $9.26K and bringing the position to 5,096 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #3507.

Tower Research Capital (TRC) first reported a position in LFMD in Q1 2021 and has held it in 22 quarters since. The position peaked at $119K in Q1 2021. 115 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Tower Research Capital (TRC) held 5,096 shares of LifeMD worth $21K as of Q2 2026.
  • Tower Research Capital (TRC) bought 2,099 LifeMD shares in Q2 2026, an estimated $9.26K.
  • LifeMD made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3507 holding.
  • Tower Research Capital (TRC) first reported a position in LifeMD in Q1 2021 and has held it in 22 quarters since.
  • Tower Research Capital (TRC)'s LifeMD position peaked at $119K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.